Trial Profile
A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Type 1 Diabetes.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2013
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 08 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2010 New trial record